About this trial
The VICAP-CPR study investigates whether doctors and nurses working in Intensive Care can determine neurological outcome and future quality of life after six months in patients treated for cardiac arrest outside the hospital based on clinical assessment in the first 24 hours after admission to Intensive Care. To conduct this study, the results of the questionnaire offered to Intensive Care doctors and nurses regarding the estimation of long-term neurological outcome and quality of life will be compared with the neurological outcome and quality of life as recorded in the STEPCARE study (NCT 05564754). The aim of the international STEPCARE study is to determine the best combination of post-resuscitation care to favourably influence survival and neurological outcome in patients treated for cardiac arrest outside hospital.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Doctors and nurses working in the Intensive Care Unit treating patients included in the STEPCARE study (NCT 05564754)
Disqualifiers
Doctors and nurses who do not have a direct treatment relationship with a patient included in the STEPCARE study
Trial population
The study population are doctors and nurses working in an Intensive Care Unit treating a patient included in the STEPCARE study (NCT 05564754) during the first 24 hours after admission to Intensive Care
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Composite endpoint of survival, good functional outcome and good quality of life 6 months after OHCA
Good functional outcome defined as modified Rankin scale 0 - 3; quality of life based on EuroQol-VAS
Secondary outcomes
Assessment of a likely poor neurological outcome based on the multimodal ICU neuroprognostication as performed in the Stepcare study NCT 05564754
Stepcare criteria for a likely poor neurological outcome are fulfilled yes or no
Sponsors and contacts
Click on the lead sponsor to view all of their trials.